secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001822479-24-000046
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q3 net rev $285M (+8.5% YoY); net income $17M vs loss $14M; reaffirms FY outlook
--------------------------------------------------------------------------------

- Q3 net revenues $285M, up 8.5% YoY (8.9% constant currency); net income $17M ($0.06 diluted) vs net loss $14M in Q3 2023.
- Adjusted EBITDA $146M, +9.0% YoY; Adjusted EPS $0.17, +$0.01 YoY.
- Nine-month 2024 net revenues $810M (+9.6% YoY); net income $32M ($0.11 diluted) vs $13M prior year.
- Reaffirming 2024 net revenue and Adjusted EBITDA outlook ranges.
- CEO cites Nordion cobalt-60 timing benefit; investor day planned for Nov 20, 2024 in NYC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000046/0001822479-24-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247924000046/shc-20241105.htm
  HTML page:      https://secwatch.observer/filing/0001822479-24-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer